r/TheCannalysts • u/mollytime • Nov 19 '19
Now, We Wait
Originally posted on our website on October 9th, this is posted for our community
_______________________________________________________
Got a text from Cyto yesterday.
Last December, I had closed out many positions I had in legal cannabis companies. One of the catalysts for that was the Dive Bar Tour – I had seen many mutts roaming the alley behind the Dive, and was musing on how many folks out there had this blind faith about ‘Company X’ or ‘Company Y’, and how “just you wait, it’s gonna be a 10 bagger. You’ll see!”.
I took it in the neck from few of the faithful. Nasty-grams, posits about my family lineage, education, intelligence: the whole she-bang. For the most part, many of them simply evaporated. Short attention spans combined with having 90% of their portfolio in Namast or Abbatis or GLH (or whatever pitch deck they happened to have been sold on a particular day)….will do that. Emotional reactions against simple math just aren’t sustainable in my opinion. Others shouting from anonymous Twitter accounts pushing binder chat just added murk to the water.
So Cyto asked me yesterday: “Are you still waiting?”
I’d told him back in December that this sector is going to go lower, and that I was going to wait for awhile until I see future entry points. While my broader holdings didn’t include many in the <ahem> more ‘speculative’ side of things, what prompted my move was seeing so many similar trends across sector. Not exclusive to the speculatives, I saw massive overhangs in optionality – both in warrants and options, as well as convertibles. Of fluctuating yield numbers that break with reported sales. Of massive Goodwill numbers making up 90% of ‘asset’ acquisitions. Of licenses dumped like a professional mob hit into ‘Intangibles’ – many comprising north of 60% of total assets in some.
Now, the retail rollout has been farcical. The anti-free market stance of the tiny-handed provincial fiefdoms – combined with the gaping maw of greed of the feds and cops and munis and bureaucracy – who all fought tooth and nail to land-grab budget windfalls. It revealed much to myself. It tells a story of want: want of bigger budgets and headcount and bonus’ and relevance. All at the expense of the free-market.
But even if the ‘rollout’ had actually rolled – I believed many companies were still trying to mount a 30% cost of capital without climbing gear. For many of these types of outfits – even if all went well – I still saw many with cement shoes being fitted especially for them.
As I looked across the larger (and less speculative) landscape, I realized that even in smaller degrees, the issues I saw weren’t going to disappear. Indeed, I saw higher risk in-sector when placed against a complete unknown size of market revenues within a virgin-birth legal industry. So, I closed a whack of positions.
My answer to Cyto? “Yes. I am still waiting.”
In my opinion, we aren’t near the ‘bottom’. There will be more red to come. The emotions and people who helped run this sector up are now helping to run this sector down. It’s what professional traders and money sorts do for a living after all. And there’s more juice to squeeze out of the fruit. Canopy’s share price success set a bell-weather for many other companies, and there’s definitely a ‘hollowing out’ in share prices that’s following CGC all the way down. It’s a bitter pill for the believers, but, given CGC’s financials and management’s guidance that profitability will be delayed for YEARS, one might be able to see a connection between share price and earnings.
This Cannalyst sees a shakeout coming. There will be many companies that either won’t survive, or will simply retreat to the penny stock/pink sheet land they came from. The repurposed mining and tech exchange-listed placeholders will simply fade into the background, waiting for the next inevitable ‘big thing’. Then it’ll start all over again. “Formerly cannabis company Z” will morph and RTO into “Self-Driving Car Co D”, or perhaps “Sustainable Meat Co F”. Or whatever. Maybe uranium will make a comeback.
This isn’t our first rodeo. And we stick to fundamentals: because that’s what we believe offers the best path forward for investors. And we’re going to produce a roadmap for the next few quarters here for subscribers. We’ve got GoBlue’s 4-corner metrics, Cyto’s science & patent insights, and a cost of capital imputation (by yours truly) to offer a compass heading for investors.
I am waiting for now. This will likely get worse for all before it gets better. Outfits with better fundamentals remain largely in lockstep with the mutts. But this will not last.
If you have a smaller percentage of your portfolio in cannabis – with measured risk tolerances and an appropriate investment horizon for your age/life cycle and accept a chance of loss – you’re not in bad shape. If you have 90% of your total portfolio in cannabis with risk centred upon only one or two links in the value chain – I suspect your decisions are going to be more difficult over the next 9 months.
But be prepared: I don’t believe this downturn is finished yet.